StockData
Brainsway Ltd. logo

Brainsway Ltd. (BWAY) stock

BWAYNasdaqSurgical & Medical Instruments & ApparatusAlso trades as BRSYF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 20, 2026Score 5/30
$9.39−0.72 (-7.12%)

Close on Nov 16, 2026Market cap $367.77MP/E 52.2Yield –

Earnings

Brainsway's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q2 FY2026
$17.10M
+35.7% on a year earlier
EPS, Q2 FY2026
$0.07
$0.05 a year earlier
Latest guidance
Raised
Aug 12, 2026 · 3 items

Quarterly results

Revenue and earnings per share from each of Brainsway's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q2 FY2026ended Jun 30, 2026Aug 12, 2026before the open$17.10M+35.7%$0.07Release
Q4 FY2025ended Dec 31, 2025Mar 11, 2026before the open$14.50M+27.2%$0.07Release
Q2 FY2025ended Jun 30, 2025Aug 13, 2025before the open$12.60M+26.0%$0.05Release
Q4 FY2024ended Dec 31, 2024Mar 11, 2025before the open$11.40M+26.7%$0.04Release
Q2 FY2024ended Jun 30, 2024Aug 6, 2024before the open$10.00M–$0.02Release
Q4 FY2023ended Dec 31, 2023Mar 6, 2024before the open$9.00M–$0.00Release
Q4 FY2022ended Dec 31, 2022Mar 15, 2023before the open–––Release
Q4 FY2021ended Dec 31, 2021Mar 9, 2022before the open–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Brainsway's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
revenueFY2026$66.00M – $68.00M–NewMar 11, 2026
RevenueGAAPFY2026$68.00M – $70.00M–NewAug 12, 2026
operating incomeFY202613% – 14%–NewMar 11, 2026
Operating incomeGAAPFY202613.5% – 14%–NewAug 12, 2026
Adjusted EBITDAnon-GAAPFY2026$13.00M – $14.00M$12.00M – $14.00MRaisedAug 12, 2026

Guidance history

Every forecast Brainsway put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Aug 12, 2026Adjusted EBITDAFY2026$13.00M – $14.00MRaised
Aug 12, 2026Operating incomeFY202613.5% – 14%New
Aug 12, 2026RevenueFY2026$68.00M – $70.00MNew
Mar 11, 2026Adjusted EBITDAFY2026$12.00M – $14.00MNew
Mar 11, 2026operating incomeFY202613% – 14%New
Mar 11, 2026revenueFY2026$66.00M – $68.00MNew
Aug 13, 2025Adjusted EBITDAFY202512% – 13%Raised
Aug 13, 2025operating incomeFY20254% – 5%Raised
Aug 13, 2025revenueFY2025$50.00M – $52.00MRaised
Mar 11, 2025Adjusted EBITDAFY202511% – 12%New
Mar 11, 2025operating incomeFY20253% – 4%New
Mar 11, 2025revenueFY2025$49.00M – $51.00MNew
Aug 6, 2024revenue guidanceFY2024$38.50M – $40.00MRaised
Mar 6, 2024annual revenuesFY2024$37.00M – $40.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Brainsway filed with the SEC as exhibits to Form 8-K or 6-K

  1. 6-K
  2. 6-K
  3. 6-K
  4. 6-K
  5. 6-K
  6. 6-K
  7. 6-K
  8. 6-K
  9. 6-K
  10. 6-K
  11. 6-K
  12. 6-K
  13. 6-K
  14. 6-K
  15. 6-K

See a number that looks wrong?